Yes, 2.5 mg of methotrexate is a very low dose. For inflammatory conditions like rheumatoid arthritis and psoriasis, weekly doses typically range from 5 to 25 mg. A single 2.5 mg tablet is actually the smallest available tablet size and is often used as a building block to reach higher weekly totals, not as a complete dose on its own.
How 2.5 mg Fits Into the Dosing Range
In rheumatoid arthritis, methotrexate is given once a week in doses ranging from 5 to 25 mg. For psoriasis, starting doses are typically 10 to 25 mg per week, with a ceiling around 30 mg. By either standard, 2.5 mg per week sits well below the usual therapeutic floor.
The 2.5 mg tablet exists because methotrexate dosing is built around it. A person prescribed 15 mg per week, for example, takes six of those tablets on a single day. The FDA-approved prescribing information lists 2.5 mg as the only standard oral tablet strength, which is why you’ll see prescriptions written as a number of 2.5 mg tablets rather than as a single larger pill.
There is one scenario where 2.5 mg tablets are taken more than once in a week as individual small doses: certain low-dose chemotherapy regimens use 2.5 mg taken two to four times per week, adding up to a maximum of 10 mg over seven days. Even in that context, each 2.5 mg dose is considered small.
Why Your Doctor Might Start This Low
Some prescribers begin at 2.5 mg per week and increase gradually, especially for patients who are older, have reduced kidney function, or are trying the medication for the first time. Starting low allows your body to adjust and gives your doctor a chance to check blood work before raising the dose. If 2.5 mg is your starting point, expect the dose to be increased over several weeks until it reaches the range where the drug is most effective for your condition.
It’s worth knowing that at 2.5 mg per week, you may not notice much benefit yet. The therapeutic effect of methotrexate for arthritis or psoriasis generally requires doses of at least 7.5 to 15 mg per week, and it can take six to eight weeks at an effective dose before symptoms noticeably improve.
Weekly Dosing Is Critical
Methotrexate for arthritis and psoriasis is taken once a week, on the same day each week. This is one of the most important safety points with this medication. Taking methotrexate daily instead of weekly, even at 2.5 mg per tablet, can cause serious and potentially fatal toxicity affecting the liver, bone marrow, and other organs. New Zealand’s medicines safety authority has specifically flagged accidental daily dosing as a recurring source of harm.
If your prescription says “2.5 mg once weekly,” that means one tablet, one day, once a week. If it says “2.5 mg tablets, take six on your methotrexate day,” that means 15 mg all taken on the same day, not spread across the week.
Side Effects at Low Doses
Even at 2.5 mg per week, side effects are possible, though they tend to be milder and less frequent than at higher doses. The most common complaints across the low-dose range include nausea, fatigue, and mouth sores. Some people feel generally unwell for a day or two after their weekly dose. Liver enzyme changes can occur at any dose, which is why regular blood tests are standard for anyone on methotrexate regardless of how small their dose is.
Folic acid supplementation helps reduce these side effects. The British Society for Rheumatology recommends at least 5 mg of folic acid once a week for anyone taking methotrexate. The most common approach is to take it the day after your methotrexate dose. If side effects persist, the folic acid can be increased to 10 mg per week, though evidence doesn’t support going higher than that. Folic acid should not be taken on the same day as methotrexate, as it may interfere with the drug’s absorption.
Low Dose vs. High Dose in Cancer Treatment
Context matters enormously with methotrexate. The 5 to 25 mg weekly range used for autoimmune conditions is already considered “low dose” in the broader medical sense. In cancer treatment, methotrexate can be given at doses hundreds or even thousands of times higher, delivered intravenously in a hospital setting with intensive monitoring. At 2.5 mg per week for an inflammatory condition, you are at the very bottom of an already low-dose category.